Nemiralisib HCl
CAS: 1254036-77-5
Ref. 3D-EAC03677
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
Nemiralisib HCl is a small molecule that inhibits the activity of two proteins, PD-L1 and p-glycoprotein (Pgp), which are involved in the immune system. Nemiralisib HCl has been shown to be effective against cancer cells and inflammatory diseases. It also has pharmacokinetic properties that make it suitable for oral administration. Nemiralisib HCl binds to and inhibits lipid kinase, which is involved in the inflammatory response. Nemiralisib HCl has terminal half-life of approximately 23 hours, with an oral bioavailability of approximately 50%.
Propiedades químicas
Consulta técnica sobre: 3D-EAC03677 Nemiralisib HCl
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
